Inhibikase Therapeutics, Inc. Share Price
Equities
IKT
US45719W2052
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 USD | -7.55% | -6.33% | +16.54% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 10.3M 823M |
---|---|---|---|---|---|
Net income 2024 * | -23M -1.84B | Net income 2025 * | -27M -2.16B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.89
x | P/E ratio 2025 * |
-1.18
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.15% |
Latest transcript on Inhibikase Therapeutics, Inc.
1 day | -7.55% | ||
1 week | -6.33% | ||
Current month | -31.48% | ||
1 month | -31.48% | ||
3 months | -53.02% | ||
6 months | +70.17% | ||
Current year | +16.54% |
Managers | Title | Age | Since |
---|---|---|---|
Milton Werner
FOU | Founder | 61 | 31/08/08 |
C. Warren Olanow
CTO | Chief Tech/Sci/R&D Officer | - | 03/01/21 |
Surendra Singh
COO | Chief Operating Officer | - | 31/03/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Berman
BRD | Director/Board Member | 73 | 31/08/19 |
Paul Grint
BRD | Director/Board Member | 66 | 21/12/20 |
Milton Werner
FOU | Founder | 61 | 31/08/08 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 1.48 | -6.92% | 29 971 |
29/04/24 | 1.59 | -7.02% | 40,442 |
26/04/24 | 1.71 | -10.00% | 98,983 |
25/04/24 | 1.9 | +1.60% | 21,668 |
24/04/24 | 1.87 | +18.35% | 62,249 |
Delayed Quote Nasdaq, April 30, 2024 at 05:50 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.54% | 10.3M | |
+0.32% | 42.86B | |
+12.31% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.76% | 25.15B | |
-23.59% | 18.63B | |
+27.61% | 12.37B | |
-3.85% | 11.92B | |
+6.59% | 11.21B |
- Stock Market
- Equities
- IKT Stock